Key clinical point: This meta-analysis suggests that ginger is safe and effective in treating migraine patients with pain outcomes assessed at 2 hours.
Major finding: Ginger treatment was associated with substantially improved pain-free at 2 hours (risk ratio [RR], 1.79; P = .04) and decreased pain scores at 2 hours (mean difference, −1.27; P less than .00001), but showed no notable influence on treatment response (RR, 2.04; P = .43). The incidence of nausea and vomiting was lower in the ginger group vs. control group. The total adverse events were similar between groups (RR, 0.80; P = .44).
Study details: A meta-analysis of 3 randomized controlled trials including 227 participants.
Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.
Source: Chen L et al. Am J Emerg Med. 2020 Nov 17. doi: 10.1016/j.ajem.2020.11.030.